Published in J Clin Invest on August 01, 1975
Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis. J Clin Invest (1977) 1.04
Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90
Restoration of "normal" membrane function in CLL cells by patients' serum. Clin Exp Immunol (1977) 0.84
Immune complexes and circulating antibodies against autologous leukaemic cells in patients with acute leukaemias. Immunology (1982) 0.75
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest (1971) 4.98
Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62
Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47
Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood (1972) 2.91
Immunoglobulins on the surface of neoplastic lymphocytes. N Engl J Med (1972) 2.63
Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med (1972) 2.47
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics (1968) 2.06
Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med (1973) 1.69
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant Rev (1973) 1.41
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis. Immunology (1974) 1.04
Surface immunoglobulins of leukaemic cells. Clin Exp Immunol (1973) 0.98
Complement-dependent cytolysis of human B lymphocytes with anti-light chain antisera. Eur J Immunol (1974) 0.83
Cytophilic antibodies in man. Ann Intern Med (1973) 0.82
Biological properties of transplantation immune sera. II. PCA in mice with H-2 antigens. Transplantation (1971) 0.81
Immunoglobulin receptors on human leukocytes. IV. Differences between bone marrow and blood cells in multiple myeloma and chronic lymphocytic leukemia: effects of therapy. J Lab Clin Med (1973) 0.79
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Generation in vitro of deletions in the broad host range plasmid RK2 using phage Mu insertions and a restriction endonuclease. Gene (1976) 4.35
Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med (1992) 4.02
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Lancet (1993) 3.84
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol (1973) 3.45
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Changing patterns in epidemiology of Crohn's disease. Lancet (1974) 2.99
Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ (1999) 2.77
Attitudes toward clinical trials among patients and the public. JAMA (1982) 2.53
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Actinomycin D: inhibition of respiration and glycolysis. Science (1966) 2.47
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. AJR Am J Roentgenol (1998) 2.24
Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med (1984) 2.24
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
After the hospital episode. Lancet (1975) 2.11
Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health (2000) 1.99
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res (1994) 1.90
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med (1981) 1.85
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med (1992) 1.85
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res (1982) 1.75
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
The measurement of food and energy intake in man-an evaluation of some techniques. Am J Clin Nutr (1980) 1.68
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 1.67
The Rand Health Insurance Study: a summary critique. Med Care (1987) 1.65
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Gluttony. 1. An experimental study of overeating low- or high-protein diets. Am J Clin Nutr (1967) 1.57
Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am J Transplant (2014) 1.56
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology (1996) 1.55
The demographic and social characteristics of patients with Crohn's disease in the Nottingham area. Scand J Gastroenterol (1976) 1.54
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst (1998) 1.50
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49
Psychosocial correlates of survival in advanced malignant disease? N Engl J Med (1985) 1.48
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol (2001) 1.48
Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev (1993) 1.45
Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr (1989) 1.42
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant (2005) 1.39
Multicystic ovarian tumor weighing 156 lbs: the second largest tumor in Texas. Tex Med (1997) 1.39
Purification of human interleukin 1. J Supramol Struct (1980) 1.38
Artifacts caused by cell microinjection. Proc Natl Acad Sci U S A (1984) 1.35
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
Human T cell antigen expression by primate T cells. Science (1982) 1.35
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Gluttony. 2. Thermogenesis in overeating man. Am J Clin Nutr (1967) 1.33
P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol (1995) 1.30
Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet (1998) 1.29
The vascular architecture of the different forms of small intestinal villi in the rat (Rattus norvegicus). Scand J Gastroenterol (1969) 1.29
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Resistance to slimming: adaptation or illusion? Lancet (1975) 1.27
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child (1984) 1.26
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology (1998) 1.22
Characterization of human IgG Fc receptors. J Immunol (1985) 1.21
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Lesions of the brachial plexus associated with fractures of the clavicle. Clin Orthop Relat Res (1969) 1.20
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat (2004) 1.19
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19
Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.18
In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol (2004) 1.17
A psychological analysis of cancer patients and their next-of-kin. Cancer (1985) 1.17
Patterns of inpatient surgeries for the top four cancers in the United States, National Hospital Discharge Survey, 1988-95. Cancer Causes Control (2000) 1.16
Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res (1985) 1.16
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15
The Ethiopia applied nutrition project. Proc R Soc Lond B Biol Sci (1976) 1.15
Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol (1998) 1.13
Intracellular compartmentalization of adenosine triphosphate. J Biol Chem (1986) 1.13
The oocyte nucleus isolated in oil retains in vivo structure and functions. Biotechniques (1992) 1.12
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF. J Immunol (1996) 1.11
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst (1984) 1.11
Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer (2000) 1.10
Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol (1991) 1.10
Failure to thrive. A continuing problem of definition. Clin Pediatr (Phila) (1989) 1.09
Comparative nutrition, growth and longevity. Proc Nutr Soc (1968) 1.09
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08